Researchers from Mass General Brigham and the Broad Institute of MIT and Harvard have identified genetic modifications that can improve the efficacy of chimeric antigen receptor (CAR)-T cell treatment ...

CAR T cells are patient-derived, genetically engineered immune cells. They are "living drugs" and constitute a milestone in modern medicine. Equipping T cells, a key cell type of the immune system, ...

SOUTH SAN FRANCISCO - A study published in Science reveals that AI-designed protein variants could potentially bypass standard biosecurity screening software, according to research led by Microsoft ...

ATLANTA--(BUSINESS WIRE)--The Family Heart Foundation, a leading research and advocacy organization, announced the online publication of recommendations from a multidisciplinary panel in the Journal ...

University of Hawaiʻi Cancer Center researchers have identified a new, less aggressive form of mesothelioma that offers patients greater hope for survival and treatment success. Led by Michele Carbone ...

In 2023, Jill Martin took a test that changed her life. She underwent genetic testing for breast cancer and learned she had a BRCA2 mutation, which increases one’s risk of developing breast and other ...

PacBio is known in the genomics space for its HiFi sequencing technology—which provides long, highly accurate reads. But today, the company is announcing its entry into the high-throughput carrier ...

Researchers from Mass General Brigham and the Broad Institute of MIT and Harvard have identified genetic modifications that can improve the efficacy of chimeric antigen receptor (CAR)-T cell treatment ...